1. Home
  2. RGEN vs MMSI Comparison

RGEN vs MMSI Comparison

Compare RGEN & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • MMSI
  • Stock Information
  • Founded
  • RGEN 1981
  • MMSI 1987
  • Country
  • RGEN United States
  • MMSI United States
  • Employees
  • RGEN N/A
  • MMSI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • MMSI Medical/Dental Instruments
  • Sector
  • RGEN Health Care
  • MMSI Health Care
  • Exchange
  • RGEN Nasdaq
  • MMSI Nasdaq
  • Market Cap
  • RGEN 6.5B
  • MMSI 5.3B
  • IPO Year
  • RGEN N/A
  • MMSI 1990
  • Fundamental
  • Price
  • RGEN $119.75
  • MMSI $82.69
  • Analyst Decision
  • RGEN Buy
  • MMSI Buy
  • Analyst Count
  • RGEN 10
  • MMSI 9
  • Target Price
  • RGEN $163.78
  • MMSI $107.00
  • AVG Volume (30 Days)
  • RGEN 706.1K
  • MMSI 540.4K
  • Earning Date
  • RGEN 11-11-2025
  • MMSI 10-29-2025
  • Dividend Yield
  • RGEN N/A
  • MMSI N/A
  • EPS Growth
  • RGEN N/A
  • MMSI N/A
  • EPS
  • RGEN N/A
  • MMSI 1.97
  • Revenue
  • RGEN $673,956,000.00
  • MMSI $1,432,816,000.00
  • Revenue This Year
  • RGEN $16.74
  • MMSI $12.79
  • Revenue Next Year
  • RGEN $13.86
  • MMSI $6.34
  • P/E Ratio
  • RGEN N/A
  • MMSI $41.87
  • Revenue Growth
  • RGEN 8.73
  • MMSI 10.11
  • 52 Week Low
  • RGEN $102.97
  • MMSI $81.04
  • 52 Week High
  • RGEN $182.52
  • MMSI $111.45
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 50.04
  • MMSI 50.03
  • Support Level
  • RGEN $112.73
  • MMSI N/A
  • Resistance Level
  • RGEN $122.71
  • MMSI $93.27
  • Average True Range (ATR)
  • RGEN 4.63
  • MMSI 1.99
  • MACD
  • RGEN -0.46
  • MMSI -3.97
  • Stochastic Oscillator
  • RGEN 55.87
  • MMSI 88.66

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: